Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries
- PMID: 1093487
- PMCID: PMC1343862
- DOI: 10.1097/00000658-197503000-00019
Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries
Abstract
Polymorphonuclear leukocytes from burned patients exhibit suppressed chemotaxis possibly related to the susceptibility of such patients to opportunistic infection. This study assesses the effect of normal serum upon burn-suppressed leukocytes and the effects of three commonly used topical chemotherapeutic agents upon the chemotaxis exhibited by granulocytes from normal controls. In vitro incubation with normal serum restored chemotaxis to normal in the suppressed granulocytes from burned patients. The serum factor responsible for this restoration was heat labile. Serum albumin alone did not exhibit this effect. Both mafenide and silver sulfadiazine suppressed the chemotactic function of granulocytes obtained from normal controls, while silver nitrate exhibited no such activity. Studies of the chemotactic function of control granulocytes after incubation with sera from burned patients yielded similar results; only the sera from patients treated with silver nitrate failed to suppress normal leukotaxis. The chemotactic impairment found in leukocytes from burned patients, however, while related to burn size and predictive of prognosis, did not vary with the agent used for the topical therapy. These data suggest the presence of a reversible intrinsic defect in leukotaxis consequent to burn injury, related to some factor deficient in burn serum. In addition, extrinsic impairment of normal granulocyte leukotaxis by two commonly used chemotherapeutic agents is demonstrated.
Similar articles
-
Topical antibacterial therapy of the burn wound.Clin Plast Surg. 1974 Oct;1(4):563-76. Clin Plast Surg. 1974. PMID: 4609669 Review. No abstract available.
-
Evaluation of a new topical agent for burn therapy. Silver sulfadiazine (silvadene).JAMA. 1974 Nov 25;230(8):1184-5. JAMA. 1974. PMID: 4479596 No abstract available.
-
A prospective analysis of silver sulfadiazine with and without cerium nitrate as a topical agent in the treatment of severely burned children.J Trauma. 1981 Jul;21(7):558-63. doi: 10.1097/00005373-198107000-00010. J Trauma. 1981. PMID: 7019454 Clinical Trial.
-
Leukopenia in acute thermal injury: evidence against topical silver sulfadiazine as the causative agent.J Burn Care Rehabil. 1989 Sep-Oct;10(5):418-20. doi: 10.1097/00004630-198909000-00008. J Burn Care Rehabil. 1989. PMID: 2793919
-
Burn therapy--a current appraisal.Surg Annu. 1971;3(0):125-47. Surg Annu. 1971. PMID: 4950708 Review. No abstract available.
Cited by
-
Sepsis in trauma patients.West J Med. 1979 Apr;130(4):378-83. West J Med. 1979. PMID: 442635 Free PMC article. No abstract available.
-
A systematic study of host defense processes in badly injured patients.Ann Surg. 1986 Sep;204(3):282-99. Ann Surg. 1986. PMID: 3019260 Free PMC article.
-
Current treatment of severely burned patients.Ann Surg. 1996 Jan;223(1):14-25. doi: 10.1097/00000658-199601000-00004. Ann Surg. 1996. PMID: 8554414 Free PMC article. Review.
-
Acne vulgaris: pathogenesis and treatment.Br Med J. 1980 Jun 14;280(6229):1394-6. doi: 10.1136/bmj.280.6229.1394. Br Med J. 1980. PMID: 6448651 Free PMC article. No abstract available.
-
Opsonic activity of blister fluid from burn patients.Infect Immun. 1983 Sep;41(3):1184-9. doi: 10.1128/iai.41.3.1184-1189.1983. Infect Immun. 1983. PMID: 6411619 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources